AzTrials
AzTrials

Venous InsufficiencyTEDECADNCT02061254

Transient Elastography DEdicated to Cosmetology And Dermatology (TEDECAD)

A study testing Cutometer, High resolution ultrasonography (echography) and Elastography in people with Venous Insufficiency and Lymphedema, run by University Hospital, Tours at 1 site in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Explorative study on a medical device with two steps. The first pilot step will be on 8 patients (4 with lymphedema and 4 with venous insufficiency). The main objective is to assess the feasibility of measures by high resolution transient elastography on these pathologic skins, and to define 3 areas for measures. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Venous Insufficiency, Lymphedema
What is being tested?
Cutometer, High resolution ultrasonography (echography) and Elastography
Could I receive a placebo?
No, everyone receives an active treatment
How many people
130 participants
Where
1 siteFrance
Study dates
Apr 2014to Jun 2015
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Patients group
  • More than 18 years old
  • Inform consent form signed
  • Affiliated to medical insurance
  • No allergy to local anaesthetic drugs known
  • For patients with lymphedema of upper limb: unilateral lymphedema occurred after a surgery and/or radiotherapy clinically confirmed by a dermatologist or a physician trained to lymphology, or primitive lymphoedema clinically confirmed by a dermatologist or a physician trained to lymphology, whom the unilateral characteristic will be proved by a recent lymphoscintigraphy (less than 2 years)
Show all 18Show fewer
  • For patients with lymphedema of lower limb: unilateral lymphedema occurred after a surgery and/or radiotherapy clinically confirmed by a dermatologist or a physician trained to lymphology, or primitive lymphoedema clinically confirmed by a dermatologist, whom the unilateral characteristic will be proved by a recent lymphoscintigraphy (less than 2 years)
  • For patients with venous insufficiency without leg ulcer: venous insufficiency without ulcer, clinically diagnosed by a dermatologist or a physician trained to angiology
  • For patients with venous insufficiency with ulcer: venous insufficiency with ulcer, clinically diagnosed by a dermatologist or a physician trained to angiology
  • Healthy group
  • Healthy volunteer
  • More than 18 years-old
  • Without any cutaneous pathology on the studied areas
  • No venous insufficiency ; this will be confirmed by a physician trained to stages of venous insufficiency and will be defined by absence of: edema, varicosities, dilated veins, telangiectasia, venous dermatitis, sclerosis, leg ulcer
  • Inform consent form signed
  • Affiliated to medical insurance
  • No allergy to local anaesthetic drugs known
  • Matched according to age (± 10 years), gender and weight (± 20 kg) to patients with venous insufficiency

Who cannot join

  • Patients group
  • History of aesthetic surgery on studied areas
  • Cutaneous abnormalities (including scars) on studied areas, except for signs of lymphedema or venous insufficiency
  • Acute or offset chronic pathology which doesn't allow long-timed explorations (according to investigator's assessment)
  • Inability to understand information and to sign the consent form (linguistics reasons or neuro-psychological)
  • Pregnant women, lactating women, and women in age for procreation and without reliable contraception or without history of hysterectomy
Show all 15Show fewer
  • Person under guardianship
  • Healthy group
  • Haemophilia or equivalent pathology
  • Cutaneous abnormalities on studied areas (including scars)
  • History of aesthetic surgery on studied areas
  • Acute or offset chronic pathology which doesn't allow long-timed explorations (according to investigator's assessment)
  • Inability to understand information and to sign the consent form (linguistics reasons or neuro-psychological)
  • Pregnant women, lactating women, and women in age for procreation and without reliable contraception or without antecedent of hysterectomy
  • Person under guardianship

Trial locations and contacts

1 site in 1 country.

France1 site
  • University Hospital of Tours

    Tours, 37044

Other trials in France

About this study

Explorative study on a medical device with two steps. The first pilot step will be on 8 patients (4 with lymphedema and 4 with venous insufficiency). The main objective is to assess the feasibility of measures by high resolution transient elastography on these pathologic skins, and to define 3 areas for measures.

The second step will be on 136 participants (48 healthy volunteers, 48 with venous insufficiency and 40 with unilateral lymphedema of a limb). The main objective is to quantify, by high resolution transient elastography, the dermal and hypodermal cutaneous fibrosis in limbs with lymphedema and venous insufficiency, and to compare it to healthy skin.

Read the detailed description

This diagnostic study will be performed in two steps, in the goal of evaluating a new device, called elastograph.

The first pilot step will be on 8 patients (4 with lymphedema and 4 with venous insufficiency). The main objective is to assess the feasibility of measures by high resolution transient elastography on these pathologic skins, and to define 3 areas for measures.

The second step will be on 136 participants (48 healthy volunteers, 48 with venous insufficiency and 40 with unilateral lymphedema of a limb). The main objective is to quantify, by high resolution transient elastography, the dermal and hypodermal cutaneous fibrosis in limbs with lymphedema and venous insufficiency, and to compare it to healthy skin.

Being tested
Cutometer, High resolution ultrasonography (echography), Elastography, Skin biopsy
Keywords
Venous insufficiency, Lymphedema, Elastograph, Ultrasonography, Fibrosis, Dermis, Hypodermis, Skin
Medical subject headings
Venous Insufficiency, Lymphedema, Fibrosis

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • CutometerDevice

    Also called Cutometer MPA 580 (Monaderm)

    3 measures by cutometer on each area: the mean value will be the final value

  • High resolution ultrasonography (echography)Device

    Also called Dermcup (Atys medical)

    Cutaneous echography on the 3 areas, in order to measure skin thickness and echogenicity Measures are blinded to cutometer (by a different investigator)

  • ElastographyDevice

    Also called high resolution elastography pulse

    10 measures on the 3 areas (central measures will be doubled) Measures will be performed blinded to cutometer

  • Skin biopsyProcedure or surgery

    Skin biopsy of 3 mm in diameter, for 30 participants, to evaluate histological fibrosis

Study groups in NCT02061254
Study groupRoleWhat they receive
3 groups of subjectsExperimental3 groups: * group of 48 healthy volunteers (matched with venous insufficiency patients) * group of 48 patients with venous insufficiency (16 with stage 1/2, 16 with stage 3/4, 16 with stage 5/6) * group of 40 patients with unilateral lymphedema (20 on upper limb (10 early stage, 10 severe stage), and 20 on lower limb (10 early stage, 10 severe stage)) Each group have the same interventions: physical examination, measures by cutometer, high resolution ultrasonography, elastography 30 persons will have a skin biopsy (15 healthy volunteers and 15 patients with venous insufficiency) For patients with lymphedema, all measures will be performed on lymphedema limb and on controlateral healthy limb
Receives: Device: Cutometer; Device: High resolution ultrasonography (echography); Device: Elastography; Procedure: Skin biopsy

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Assessment of dermal/hypodermal fibrosis in lymphedema and venous insuffisency

    • Step 1: follow-up of the shear waves spreading, in cutaneous tissues, within 2-3 mm
    • Step 2: measure of fibrosis of the cutaneous tissue, by transient elastography (elastograph, in kPa)

    Measured: One day

Secondary outcomes (6)
  1. Cutaneous fibrosis measured by cutometer

    Cutaneous fibrosis measured by cutometer

    Measured: One day

  2. Cutaneous fibrosis assessed by histology

    Cutaneous fibrosis assessed by histology (skin biopsies), using a semi-quantitative scale (0 to 3, from no fibrosis to major fibrosis) Analysis of the samples will be performed altogether at the end of inclusions.

    Measured: 12 months

  3. Cutaneous thickness measured by high resolution ultrasonography

    Cutaneous thickness measured by high resolution ultrasonography (in mm)

    Measured: One day

  4. Clinical score of fibrosis

    Clinical score of fibrosis, assessed by a scale from 0 (normal skin) to 3 (severe fibrosis): this score is derived from modified Rodnan skin score used in scleroderma

    Measured: One day

  5. Echogenicity of the dermis and superficial hypodermis

    Echogenicity of the dermis and superficial hypodermis assessed by high resolution ultrasonography

    Measured: One day

  6. Assessement of adverse events

    Assessement of adverse events (pain with a visual analogic scale from 0 to 100, infections of the site of skin biopsies, others)

    Measured: 15 days

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted12 Feb 2014 (estimated)
  2. Study startApr 2014
  3. Primary completionJun 2015
  4. Study completionJun 2015

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Diagnosis
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
130 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02061254
Sponsor's protocol ID
PFUI 2013 - AM / TEDECAD
Acronym
TEDECAD
Status last verified
Aug 2015
First submitted
10 Feb 2014
Last updated
26 Dec 2025
Results posted
No
Data monitoring committee
No

Publications

  • Mofid Y, Faleweei G, Chartier C, Machet L, Vierron E, Gissot V, Tauveront V, Georgescou G, Dujardin PA, Machet MC, Kervarrec T, Patat F, Ossant F, Maruani A. High-Frequency Transient Elastography Prototype to Assess Skin (Dermis) Fibrosis: A Diagnostic Study in Patients with Venous Insufficiency and Controls. Ultraschall Med. 2021 Oct;42(5):503-513. doi: 10.1055/a-1047-3146. Epub 2020 Mar 18.

    PubMed 32187631

Questions about this trial

What is this clinical trial studying?

A study testing Cutometer, High resolution ultrasonography (echography) and Elastography in people with Venous Insufficiency and Lymphedema, run by University Hospital, Tours at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 18 inclusion and 15 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 26 Dec 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Assessment of dermal/hypodermal fibrosis in lymphedema and venous insuffisency (time frame: One day). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02061254, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 26 Dec 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in